Chun Liu

Ms. Chun Liu

The University of Queensland, Brisbane, Queensland, Australia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Acta Biomaterialia
Verified
Journal Article
Open access
CLChun Liu
Chun Liu
NYNegar Yazdani
Negar Yazdani
CMCorey S. Moran
Corey S. Moran
CSCarlos Salomon
Carlos Salomon
CSChaminda Jayampath Seneviratne
Chaminda Jayampath Seneviratne
Pingping HanPingping Han
Pingping Han
Bacterial extracellular vesicles (BEVs) are naturally occurring bioactive membrane-bound nanoparticles released by both gram-negative and positive bacterial species, exhibiting a multifaceted role in mediating host-microbe interactions across various physiological conditions. Increasing evidence supports BEVs as essential mediators of intercellular exchange, influencing bacterial pathogenicity, disease mechanisms, and modulating the host immune response. However, the extent to which these BEV-mediated actions can be leveraged to predict disease onset, guide treatment strategies, and determine clinical outcomes remains uncertain, particularly in terms of their clinical translation potentials. This review briefly describes BEV biogenesis and their internalisation by recipient cells and summarises methods for isolation and characterization, essential for understanding their composition and cargo. Further, it discusses the potential of biofluid-associated BEVs as biomarkers for various diseases, spanning both cancer and non-cancerous conditions. Following this, we also outline the ongoing human clinical trials of using BEVs for vaccine development. In addition to disease diagnostics, this review explores the emerging research of using natural or engineered BEVs as smart nanomaterials for applications in anti-cancer therapy and bone regeneration. This discussion extends to key factors for unlocking the clinical potential of BEVs, such as standardization of BEVs isolation and characterisation, as well as other hurdles in translating these findings to the clinical setting. We propose that addressing these hurdles through collaborative research efforts and well-designed clinical trials holds the key to fully harnessing the clinical potential of BEVs. As this field advances, this review suggests that BEV-based nanomedicine has the potential to revolutionize disease management, paving the way for innovative diagnosis, therapeutics, and personalized medicine approaches. STATEMENT OF SIGNIFICANCE: Extracellular vesicles (EVs) from both host cells and bacteria serve as multifunctional biomaterials and are emerging in the fields of biomedicine, bioengineering, and biomaterials. However, most of the current studies focus on host-derived EVs, leaving a gap in comprehensive research on bacteria-derived EVs (BEVs). Although BEVs offer an attractive option as nanomaterials for drug delivery systems, their unique nanostructure and easy-to-modify functions make them a potential method for disease diagnosis and treatment as well as vaccine development. Our work among the pioneering studies investigating the potential of BEVs as natural nanobiomaterials, plays a crucial role in both understanding the development of diseases and therapeutic interventions.

13 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
ALAndrew Liaw
Andrew Liaw
CLChun Liu
Chun Liu
Saso IvanovskiSaso Ivanovski
Saso Ivanovski
Pingping HanPingping Han
Pingping Han
Background: Periodontitis is a chronic inflammatory disease involving an interplay between bacteria, inflammation, host response genes, and environmental factors. The manifestation of epigenetic factors during periodontitis pathogenesis and periodontal inflammation is still not well understood, with limited reviews on histone modification with periodontitis management. This scoping review aims to evaluate current evidence of global and specific DNA methylation and histone modification in periodontitis and discuss the gaps and implications for future research and clinical practice. Methods: A scoping literature search of three electronic databases was performed in SCOPUS, MEDLINE (PubMed) and EMBASE. As epigenetics in periodontitis is an emerging research field, a scoping review was conducted to identify the extent of studies available and describe the overall context and applicability of these results. Results: Overall, 30 studies were evaluated, and the findings confirmed that epigenetic changes in periodontitis comprise specific modifications to DNA methylation patterns and histone proteins modification, which can either dampen or promote the inflammatory response to bacterial challenge. Conclusions: The plasticity of epigenetic modifications has implications for the future development of targeted epi-drugs and diagnostic tools in periodontitis. Such advances could be invaluable for the early detection and monitoring of susceptible individuals.

11 December 2025 in Extracellular Vesicles and Circulating Nucleic Acids
Verified
Journal Article
Open access
CZChenyi Zhang
Chenyi Zhang
CLChun Liu
Chun Liu
ALAndrew Liaw
Andrew Liaw
Saso IvanovskiSaso Ivanovski
Saso Ivanovski
Pingping HanPingping Han
Pingping Han
Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of both soft (gingiva and periodontal ligament) and hard (cementum and alveolar bone) supporting tissues. The complex periodontal microenvironment often limits the effectiveness of current clinical treatments in achieving functional tissue regeneration. Although mesenchymal and immune cell-based therapies hold promise, concerns related to cell viability and immune compatibility limit their clinical translation. As a natural secretome, small extracellular vesicles (sEVs) are cell-secreted nanoparticles that deliver bioactive molecules for cell-to-cell communication to modulate immune response and promote tissue regeneration. To assess the translational readiness of sEVs therapy, this scoping review first outlines the current clinical trials of mesenchymal stem cells (MSCs)-sEVs in periodontitis, followed by a transition to preclinical application of integrating sEVs with biomaterial scaffolds to enhance localized regenerative outcomes. We then analyzed eight preclinical studies utilizing 3D bioprinted MSCs-sEVs/human umbilical vein endothelial cells-sEVs (or immune cell-derived sEVs) constructs in bone and vasculature regeneration models, and one study related to in vitro periodontal regeneration. These constructs exhibited improved outcomes in osteogenesis, angiogenesis, and immunomodulation, supporting their potential for future translational applications in periodontal therapy. Given the early stage of bioprinted sEVs constructs in periodontitis, we outline critical research gaps and potential future directions to overcome current technical and biological challenges. Together, this review demonstrated the translational trajectory of sEV-based strategies for periodontal regeneration. It offers a potential roadmap for utilizing sEV-based periodontal regeneration across clinical, preclinical, and biofabrication applications, highlighting their potential as next-generation, cell-free therapeutics in regenerative periodontics.

5 June 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
CLChun Liu
Chun Liu
CZChenyi Zhang
Chenyi Zhang
SHShu Hua
Shu Hua
CSCarlos Salomon
Carlos Salomon
Saso IvanovskiSaso Ivanovski
Saso Ivanovski
Pingping HanPingping Han
Pingping Han
Biomaterials could influence the production and composition of cell derived extracellular vesicles (EVs), including osteoblast-derived EVs (OB-EVs), which are essential for cell-to-cell communication and hold potential for bone regeneration. Despite their promise, methods for enhancing OB-EVs yields, especially from 3D highly porous microfibrous polymeric scaffolds, remain limited. In this study, we cultured mouse osteoblasts cell line MC3T3-E1 on 3D melt electrowritten (MEW) medical grade polycaprolactone (mPCL) scaffolds and 2D tissue culture plates (TCPs) to compare EV yield, subtypes (small EVs, microvesicles, apoptotic bodies), and proteome profile using liquid chromatography coupled with Tandem mass spectrometry (LC/MS-MS). Our results revealed that OB cultured on MEW mPCL scaffolds significantly increased small EVs yield, with increased particles of small EVs and reduced apoptotic bodies. Notably, two 30 × 30 mm, 0.8 mm-thick MEW mPCL scaffolds (5.07 × 108 sEVs per scaffold) produced the same sEVs yield comparable to that of a T175 TCP flask (9.37 × 108 sEVs per flask). The LC-MS/MS results showed that MEW mPCL sEVs were enriched for 34 proteins associated with tight junction, cell adhesion, gap junction, proteasome, apoptosis and complement pathways. Key proteins such as tubulin superfamily members, myosin heavy chain 9, ezrin, complement 3, CD9, Decorin, and Biglycan were identified, all potentially contributing to tissue repair and regeneration. These findings suggest that 3D MEW mPCL scaffolds not only enhanced OB-sEVs production but also enriched sEVs-protein profiles, particularly those involved in cell–cell junctions and phagosome secretion, suggesting their strong potential in bone tissue engineering.

29 September 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
Pingping HanPingping Han
Pingping Han
CLChun Liu
Chun Liu
AAAbdala Abdal-Hay
Abdala Abdal-Hay
SRSarah Reed
Sarah Reed
ALAndrew Liaw
Andrew Liaw
Saso IvanovskiSaso Ivanovski
Saso Ivanovski
Replicating the structural complexity of polymicrobial oral biofilms in vitro remains a significant challenge in biomaterials research. Nevertheless, developing clinically relevant biofilm models is crucial for advancing our understanding of biofilm–host interactions and elucidating how biomaterials influence microbial composition, behaviour, and overall biofilm dynamics. In this work, 3D biomimetic fibrous scaffolds made from medical-grade polycaprolactone (mPCL) were fabricated using the melt electrowriting (MEW) technique. The effects on biofilm viability, activity, microbiome, and proteome profiles were assessed on 3D fibrous scaffolds and conventional 2D tissue culture plates (TCP). Human saliva was cultured on MEW mPCL (3D BF) and TCP (2D BF) for 4 days, followed by microbiome profiling via 16S rRNA sequencing and proteomic analysis using LC–MS/MS, SWATH with GO and KEGG pathway enrichment. The results demonstrated that 3D MEW mPCL scaffolds enhanced biofilm biomass, thickness, and viability. Microbiome analysis revealed that 3D BF was enriched with both commensals and pathogens, including Veillonella, Peptostreptococcus, Porphyromonas gingivalis, and Treponema denticola, alongside probiotic species like Lactobacillus acidophilus. Pooled proteomic data from three technical repeats, along with GO and KEGG analyses, revealed a functionally dynamic biofilm ecosystem characterised by elevated expression of proteins involved in glycolysis, the TCA cycle, and nucleotide metabolism, highlighting pathways essential for biofilm survival, stress adaptation, and host interaction. These ‘proof-of-concept’ findings highlight the potential of 3D MEW fibrous mPCL scaffolds as a biomimetic 3D platform capable of accurately recapitulating the dynamic spatial and metabolic complexity of oral biofilms, thereby facilitating innovative investigations into microbial ecology, host–pathogen interactions, and the accelerated development of targeted antimicrobial therapies.

3 September 2026 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
CLChun Liu
Chun Liu
JWJenny Wang
Jenny Wang
ALAndrew Liaw
Andrew Liaw
YNYANG NING
YANG NING
ALAndrew Lai
Andrew Lai
Pingping HanPingping Han
Pingping Han